Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-03-10 Sale |
2021-03-12 5:40 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
5,566 | $362.92 | $2,019,996 | 55,558 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-24 7:57 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,079 | $406.98 | $439,131 | 55,823 (Direct) |
View |
| 2021-02-19 Sale |
2021-02-23 6:33 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,800 | $420.01 | $756,025 | 56,902 (Direct) |
View |
| 2021-01-22 Sale |
2021-01-25 8:21 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,079 | $368.82 | $397,960 | 58,702 (Direct) |
View |
| 2020-12-23 Sale |
2020-12-28 5:43 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,079 | $359.85 | $388,276 | 59,781 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-25 4:50 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,079 | $318.99 | $344,190 | 60,860 (Direct) |
View |
| 2020-10-23 Sale |
2020-10-27 6:20 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,079 | $403.18 | $435,030 | 61,939 (Direct) |
View |
| 2020-09-30 Sale |
2020-10-02 6:08 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
2,200 | $411.2 | $904,637 | 63,018 (Direct) |
View |
| 2020-09-25 Sale |
2020-09-28 5:35 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
2,000 | $400.07 | $800,137 | 65,218 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-24 4:30 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,079 | $395.11 | $426,324 | 67,218 (Direct) |
View |
| 2020-09-09 Sale |
2020-09-11 6:58 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
4,580 | $398.3 | $1,824,223 | 68,297 (Direct) |
View |
| 2020-08-24 Sale |
2020-08-26 7:04 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,531 | $427.24 | $654,107 | 72,877 (Direct) |
View |
| 2020-07-23 Sale |
2020-07-27 5:53 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,531 | $427.31 | $654,213 | 74,408 (Direct) |
View |
| 2020-06-23 Sale |
2020-06-25 6:45 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,531 | $409.37 | $626,750 | 75,939 (Direct) |
View |
| 2020-05-22 Sale |
2020-05-27 6:06 pm |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
1,531 | $396.74 | $607,409 | 77,470 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-03-08 Option Award |
2021-03-10 7:28 pm |
N/A N/A |
DEXCOM INC | DXCM | Pacelli Steven Robert EVP Strategy and Corporate Dev |
5,301 | $0.001 | 61,124 (Direct) |
View |